TTR mouse Monoclonal Antibody(6E5)

This gene encodes transthyretin, one of the three prealbumins including alpha-1-antitrypsin, transthyretin and orosomucoid. Transthyretin is a carrier protein; it transports thyroid hormones in the plasma and cerebrospinal fluid, and also transports retinol (vitamin A) in the plasma. The protein consists of a tetramer of identical subunits. More than 80 different mutations in this gene have been reported; most mutations are related to amyloid deposition, affecting predominantly peripheral nerve and/or the heart, and a small portion of the gene mutations is non-amyloidogenic. The diseases caused by mutations include amyloidotic polyneuropathy, euthyroid hyperthyroxinaemia, amyloidotic vitreous opacities, cardiomyopathy, oculoleptomeningeal amyloidosis, meningocerebrovascular amyloidosis, carpal tunnel syndrome, etc.

Introducing the TTR Mouse Monoclonal Antibody (6E5), a cutting-edge product designed to revolutionize the field of biomedical research. This highly specialized antibody is meticulously crafted to target and detect Transthyretin (TTR), a protein of utmost significance in various physiological processes.

The TTR Mouse Monoclonal Antibody (6E5) boasts exceptional specificity and sensitivity, enabling researchers to accurately identify and quantify TTR in a wide range of biological samples. Its unrivaled performance is attributed to the advanced hybridoma technology employed during its development, ensuring the production of a highly pure and reliable antibody.

With its remarkable affinity for TTR, this antibody facilitates the elucidation of TTR's role in numerous pathological conditions, including neurodegenerative disorders and amyloidosis. By utilizing the TTR Mouse Monoclonal Antibody (6E5), researchers can gain invaluable insights into the molecular mechanisms underlying these diseases, paving the way for the development of novel therapeutic interventions.

Furthermore, this antibody's versatility extends beyond research applications, as it can be employed in diagnostic assays to detect TTR aberrations in patient samples. Its exceptional performance characteristics, such as low cross-reactivity and minimal background noise, ensure accurate and reliable results, making it an indispensable tool in clinical laboratories.

The TTR Mouse Monoclonal Antibody (6E5) is supplied in a convenient and user-friendly format, allowing for seamless integration into various experimental protocols. Its long shelf life and stability guarantee consistent performance, eliminating concerns regarding antibody degradation and batch-to-batch variability.

In summary, the TTR Mouse Monoclonal Antibody (6E5) represents a breakthrough in the field of biomedical research, offering unparalleled specificity, sensitivity, and reliability. Whether investigating TTR's role in disease pathogenesis or diagnosing TTR-related disorders, this antibody is an indispensable asset for scientists and clinicians alike.